Incumbents and Insurgents in Healthcare

Dario Amodei

53 min · 6. jan. 2026
Billede af episoden Dario Amodei

Beskrivelse

In this episode of Incumbents and Insurgents, Eric Larsen speaks with Dario Amodei, Co-Founder and CEO of Anthropic, about what happens when rapidly improving AI systems meet a healthcare sector built for stability and caution. They discuss the pace of model progress, why healthcare’s labor intensity and administrative burden make it especially exposed, and where AI is already acting as a clinical second opinion. The conversation spans physician workflows, biomedical discovery, and the gap between invention and diffusion, before turning to what increasingly capable machines mean for human judgment, creativity, and the role of the humanities in an age of abundant intelligence.

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Incumbents and Insurgents in Healthcare-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

6 episoder

Billede af episoden Tom Mihaljevic and Elad Walach

Tom Mihaljevic and Elad Walach

In this episode of Incumbents and Insurgents, Eric Larsen hosts Tom Mihaljevic, M.D. (CEO and President, Cleveland Clinic) and Elad Walach (Co-Founder and CEO, Aidoc) for the series' first in-person pairing of an Incumbent and an Insurgent. They explore why AI applied to poorly structured health systems fails without standardization and manufacturing discipline; how 370,000 annual deaths from diagnostic errors could worsen as the standard of care accelerates beyond the system's capacity to implement it; and why Aidoc's recent clinical-grade foundation model for medical imaging may mark the beginning of comprehensive AI-driven disease detection. They also discuss what Cleveland Clinic learned building a world-class hospital in Abu Dhabi from scratch, why executive leadership is the single best predictor of AI implementation success, and whether U.S. healthcare's fragmentation is incompatible with the diffusion of transformational technology.

15. apr. 20261 h 10 min